Eltoukhy Helmy 4

What Happened

• Guardant Health CEO Helmy Eltoukhy had restricted stock units (RSUs) convert to common shares (reported as derivative exercises). A total of 36,529 shares were issued to him (zero exercise price), and the company retained 18,514 of those shares to satisfy tax-withholding obligations, resulting in net delivery of 18,015 shares to the insider.
• The company withheld 1,428 shares on 2026-06-30 at $150.03 per share ($214,243) and 17,086 shares on 2026-07-01 at $170.77 per share ($2,917,776), for total withholding of $3,132,019.

Key Details

• Transaction dates and prices:
  • 2026-06-30: 2,817 RSU conversions (no cash exercise); 1,428 shares withheld @ $150.03 (F)
  • 2026-07-01: 23,997 and 9,715 RSU conversions (no cash exercise); 17,086 shares withheld @ $170.77 (F)
• Net shares retained by the insider after withholding: 18,015 shares.
• Footnotes: F1 confirms shares were retained by the company only to meet tax withholding and not in excess; F2, F4, F5 describe the RSU grants and vesting schedules (grants from Mar 17, 2026; Mar 18, 2024; Mar 12, 2025) and their vesting cadence.
• Filing: Form 4 filed 2026-07-02 for transactions through 2026-06-30/07-01; filing appears timely based on the reported dates. The filing did not disclose total beneficial ownership post-transaction in the extract provided.

Context

• These were RSU vesting events (reported as derivative exercises at $0 exercise price), with the company withholding shares to cover taxes — a routine "net settlement" method, not an open-market sale by the insider.
• Withholding dispositions are administrative/tax-related and do not by themselves indicate a change in the insider’s view of the company.